Interazioni tra farmaci
Nirsevimab + Palivizumab
Gravità: Moderata
Nirsevimab and Palivizumab: moderate interaction.
Ultimo aggiornamento
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
Sintesi
Both are monoclonal antibodies that provide passive RSV protection and are used for the same indication. Giving both offers no added benefit and exposes the infant to unnecessary dosing.
Cosa significa questa interazione in parole semplici
Nirsevimab and Palivizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Nirsevimab belongs to Miscellaneous; Palivizumab belongs to Miscellaneous.
Perché avviene
Therapeutic duplication of RSV F-protein-targeting antibodies; no pharmacokinetic interaction is established.
Cosa fare
Do not give palivizumab to infants who have already received nirsevimab in the same RSV season. For infants who had palivizumab first, follow the labeled guidance on switching.
Cosa chiedere al farmacista
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Nirsevimab e Palivizumab, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Provi Pro+ gratis per 7 giorni sul web. Nessuna carta.
Domande frequenti
Can I take Nirsevimab with Palivizumab?
MediHelp rates the interaction as moderate. Nirsevimab and Palivizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both are monoclonal antibodies that provide passive RSV protection and are used for the same indication. Giving both offers no added benefit and exposes the infant to unnecessary dosing.
How serious is the interaction between Nirsevimab and Palivizumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not give palivizumab to infants who have already received nirsevimab in the same RSV season. For infants who had palivizumab first, follow the labeled guidance on switching.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
